Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
alg-1001 (3 trials)
bevacizumab (avastin) (1 trial)
magnesium (2 trials)
potassium chloride (klor-con) (2 trials)
risuteganib (3 trials)
sodium acetate (2 trials)
sodium chloride (2 trials)
zinc dichloride (2 trials)
Diabetic Retinopathy (Phase 2)
Edema (Phase 2)
Geographic Atrophy (Phase 2)
Macular Degeneration (Phase 2)
Macular Edema (Phase 2)
Retinal Diseases (Phase 2)
Tissue Adhesions (Phase 2)
Trials (6 total)
Trial APIs (8 total)